Module

Application of Non–HIV-Specific Management Strategies for Dyslipidemia in HIV-Infected Patients

Source: Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

Application of Non–HIV-Specific Management Strategies for Dyslipidemia in HIV-Infected Patients


Faculty:

Pablo Tebas, MD
  • Pablo Tebas, MD

CME CREDIT INFORMATION

Release Date: 01/12/07

Expiration Date: 01/11/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss lipid management strategies in the setting of HIV infection, including discussion of complications that arise in the context of antiretroviral therapy
  • Discuss the data on the outcomes of therapy with fibrates and statins in HIV-infected patients
  • Describe the use of nonpharmacologic interventions and the impact relative to lipid-lowering therapy

Topics covered include:

  • Introduction
  • Lipid Risk Factors for Cardiovascular Disease
  • Nonlipid Risk Factors for Cardiovascular Disease
  • Dyslipidemia: Goals of Therapy
  • Therapeutic Life Changes in HIV-Infected Individuals
  • Pharmacologic Treatment of Dyslipidemia
  • Lipid-Lowering Drug Treatment: Statins
  • Lipid-Lowering Drug Treatment: Fibrates
  • Lipid-Lowering Drug Treatment: Ezetimibe
  • Lipid-Lowering Drug Treatment: Niacin
  • Alternative Lipid-Lowering Therapies: Fish Oil
  • Conclusion
  • Summary: Clinical Implications
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.